Vera Health, a clinical artificial intelligence search engine, has secured $28.5 million in Series A funding to expand its platform. The funding round was led by Threshold Ventures, with participation from Optum Ventures, Mantis VC, and SV Angel. Existing investors Y Combinator and Gradient tripled their investments in the round, according to the company’s October 27 announcement.
Vera Health plans to use the new capital to invest in its evidence infrastructure, expand internationally, develop partnerships, and grow its team. According to company executives, the business has raised $32 million in total funding to date.
Platform Focuses on Medical Evidence
Vera Health’s platform searches more than 60 million peer-reviewed publications, clinical guidelines, consensus statements and drug labels, according to its executives.
Co-founder Taieb Bennani shared that the company’s approach rests on four principles: honesty, traceability, transparency, and context. He explained that the platform searches for evidence before generating an answer, distinguishing its approach from language models that can produce plausible-sounding statements without necessarily providing verifiable information.
“The first, and for me the most important, is honesty,” Bennani said.
Emily Melton, co-founder and managing partner at Threshold Ventures, said Vera enables clinicians to find and assess the research behind medical decisions while making the strengths and limitations of the evidence visible. She also described the platform as a clinical intelligence layer that brings evidence to the point of care.
Clinician Adoption Across 190 Countries
Vera Health’s search engine is used by more than 800,000 clinicians in 190 countries, compared with a few thousand users a year earlier, Bennani said.
According to the co-founder, much of the platform’s growth has come through recommendations from other clinicians rather than a large sales operation. He also reported that Vera had been the most downloaded clinical application worldwide across the Apple App Store and Google Play every month since June.
Bennani said the application received more downloads in September than several of the largest competitors in its market combined. He attributed the platform’s continued use to clinicians’ trust in the service and said demand extended across countries, specialties and health systems.
Reducing the Gap Between Research and Practice
Bennani highlighted the time required for medical knowledge to reach clinical practice as an issue addressed by the company’s mission. He cited research published in the Journal of the Royal Society of Medicine, which estimates that new medical knowledge takes 17 years to reach clinical practice.
Bennani said Vera aims to reduce the gap between existing medical knowledge and the information patients receive, with the goal of making that process take seconds rather than years.
Team Growth and Market Competition
Vera Health also plans to expand its workforce as it grows in international markets. Bennani said the company had increased its team from six to 12 people while reaching more than 800,000 clinicians. He added that Vera was hiring internationally as it expanded in local markets.
The clinical AI and medical search market includes established clinical reference services such as Elsevier’s ClinicalKey and Wolters Kluwer’s UpToDate. Other competitors include AI-based platforms OpenEvidence and Doximity Ask, as well as technology companies OpenAI and Anthropic.
Vera Health Raises $28.5 Million in Series A Funding
Vera Health has raised $28.5 million in Series A funding to expand its artificial intelligence-powered clinical search platform and accelerate international growth. Announced on October 27, 2026, the investment round was led by Threshold Ventures, with participation from Mantis VC and SV Angel. Existing investors Y Combinator and Gradient also increased their investments, bringing Vera Health’s total funding to $32 million. The funding will support improvements to the company’s medical evidence infrastructure, expansion into additional markets, and partnerships with medical societies, publishers, and healthcare systems.
